Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
22 hedge funds and large institutions have $3.54M invested in Psychemedics Corporation in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
4% less funds holding
Funds holding: 23 → 22 (-1)
7% less capital invested
Capital invested by funds: $3.82M → $3.54M (-$277K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$5.64K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$5.57K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.85K |
| 4 |
YAL
Your Advocates Ltd
Houston,
Texas
|
+$3.33K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$231K |
| 2 |
Renaissance Technologies
New York
|
-$18.1K |
| 3 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
-$12.6K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.66K |
| 5 |
BlackRock
New York
|
-$1.65K |
PMD Hedge Fund Activity: Q1 2024 in Review
22 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q1 2024, worth a combined $3.54M — down 7.2% from $3.82M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PMD and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 8 added.
The largest buyer was Wedbush Securities, adding an estimated $5.64K. The largest seller was Ancora Advisors, exiting entirely with an estimated $231K sold.
- 22 institutional investors held Psychemedics Corporation (PMD) as of Q1 2024, down from 23 in Q4 2023.
- Funds reported $3.54M of Psychemedics Corporation stock for Q1 2024, down 7.2% quarter-over-quarter.
- 1 fund opened new Psychemedics Corporation positions in Q1 2024 and 2 closed out, a net change of -1 holder.
- The largest Psychemedics Corporation buyer in Q1 2024 was Wedbush Securities, an estimated $5.64K added.
- The largest Psychemedics Corporation seller in Q1 2024 was Ancora Advisors, an estimated $231K sold.
Based on aggregated 13F filings for Q1 2024.